Sign in

NCT07388342Recruiting

Diagnostic Accuracy of ECG-less Gated Cardiac CT in Resuscitated Cardiac Arrest Survivors Without ST Elevation Myocardial Infarction

Diagnostic Accuracy of ECG-less Gated Cardiac CT in Resuscitated Cardiac Arrest Survivors

Source: ClinicalTrials.gov · Last updated 5 Feb 2026

Brief summary (registry, in English)

In a significant portion of patients surviving a cardiac arrest, the event is caused by a myocardial infarction (a narrowing or blockage of one or more blood vessels that supply blood to the heart, the coronary arteries). In some people, this is immediately evident from basic tests; in others, it is more difficult to predict with the currently available tests whether this (or something else) caused the cardiac arrest. We investigate a technique that allows us to also assess the coronary arteries on the CT scan that is performed in patients surviving a cardiac arrest. The coronary angiography is currently the best exam we have for examining the coronary arteries, but it has some disadvantages. Compared to the CT scan, it takes more time, needs a more complex access to the blood vessels, and has some rare but relevant possible complications. The major advantage of the coronary angiography is that there is the possibility of immediate treatment of a narrowed/blocked blood vessel of the heart. The current guidelines advice an urgent coronary angiography when a clear myocardial infarction is suggested on the electrocardiogram, but not when there is no clear indication of myocardial infarction. Nonetheless, a relevant portion (more or less 40%) of the patients without a clearly abnormal electrocardiogram, still have an important problem in the blood vessels of the heart. We aim to determine whether the CT scan provides accurate information about the condition of the blood vessels of the heart. The CT scan was already well examined for this purpose before, but in the currently conventional way it needs preparation with extra monitoring and administration of medication, which would lead to loss of precious time and potentially dangerous side effects of these drugs in this critical situation. For that reason, a new software modality was developed that allows us to examine the coronary arteries in the same CT scan, without need for additional monitoring or medication administration. It does not need additional contrast administration (the dye necessary for optimal evaluation of some diseases). The goal of this study is to determine whether this new technique gives us the correct information about the coronary arteries. This means we acquire the images of the heart in the same scan, and verify the results with the conventional coronary angiography. If the technique provides accurate information, it could lead to a better selection of patients we need to urgently refer for a coronary angiography and to defer the exam in those who have normal coronary arteries on the scan.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
15 Oct 2025
Start date
1 Sept 2025
Primary completion date
1 Sept 2027
Lead sponsor
Universitair Ziekenhuis Brussel
NCT number
NCT07388342

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 1 Sept 2025 to the primary completion date, 1 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Inclusion:
    • Adults (≥18 years) with sustained return of spontaneous circulation (ROSC) following in/out-of-hospital cardiac arrest.
    • Informed consent from patient or representative obtained before invasive coronary angiography.
  • Exclusion
    • Patients on VA-ECMO
    • ACS STEMI or STEMI "equivalent"
    • New left/right bundle branch block
    • ST segment depression in leads V1-V3, when the terminal T wave is positive and concomitant ST-segment elevation ≥ 0,5mm recorded in leads V7-V9 (posterior MI)
    • ST-segment elevation in V7-V9 (posterior MI) or V3R-V4R (RV MI)
    • ACS NSTEMI with persistent ST depression despite optimal therapy, suggesting ongoing myocardial ischemia, with indication for an urgent ICA according to the treating physician.
    • Hemodynamic/electrical instability precluding CT imaging (as perceived by the treating physician)
    • Life-threatening arrhythmia potentially caused by acute myocardial ischemia
    • Absolute contraindications to iodinated contrast
    • Patients with a known non-cardiac cause of cardiac arrest (e.g., traumatic brain injury, overt hemorrhage, asphyxia/severe hypoxia due to known lung disease, trauma, severe metabolic/electrolyte derangement, or intoxication) as perceived by the treating physician, where chest CT is considered unnecessary.
    • Known or likely pregnancy or lactation
    • Severe bleeding issue (as perceived by the treating physician) precluding heparin administration during radial access coronary angiography.
    • Prior coronary intervention (stent implantation/CABG).
    • CT findings indicating a condition that precludes coronary angiography in the short term.
    • Patients with end-of-life care pathways.
    • Participation in another intervention study interfering with the research questions in OPEN CCT Arrest.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universitair Ziekenhuis Brussel (UZB)
Coordinator of this site? Confirm its status
BrusselsBelgiumRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.